{"acquisitions":[],"changes":[],"country":"CH","description":"Oculis is a clinical-stage ophthalmology company developing topical and systemic treatments for serious eye conditions including diabetic macular edema, glaucoma, and dry-eye disease. Its OCS-01 dexamethasone eye drop uses a nanoparticle platform that delivers drug into the posterior segment without injection.","domain":"oculis.com","employees":null,"founded":2017,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":46.521827,"lng":6.632702,"location":"Lausanne, Switzerland","multiples":[],"name":"Oculis","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":114480000,"connectionsAmong":[],"currency":"EUR","date":"2025-08-15","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"oculis-com-2025-08-15-growth","source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"oculis-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"oculis.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://oculis.com"},{"fact":"description","publisher":"oculis.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://oculis.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Cloudflare","WordPress","Google Tag Manager","GSAP 3.12.5","Cloudflare Bot Management","Cookiebot","WP Engine","WP Rocket 3.21.3","PHP","MySQL","jquery 3.7.1"],"totalRaisedUsd":114696000,"traction":[],"updatedAt":"2026-05-07","valuations":[]}